{"id":780873,"date":"2023-08-30T07:19:42","date_gmt":"2023-08-30T11:19:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/"},"modified":"2023-08-30T07:19:42","modified_gmt":"2023-08-30T11:19:42","slug":"eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/","title":{"rendered":"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WATERTOWN, Mass., Aug.  30, 2023  (GLOBE NEWSWIRE) &#8212; EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that the Company will participate at the following upcoming conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Citi&#8217;s 18<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual BioPharma Conference<br \/><\/strong>Forum: 1&#215;1 Investor Meetings<br \/>Date: Wednesday, September 6, 2023<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:left\">\n          <strong>H.C. Wainwright 25<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Investment Conference<br \/><\/strong>Forum: Corporate Presentation<br \/>Date: Monday, September 11, 2023<br \/>Time: Available on-demand at 7:00 a.m. ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Baird 2023 Global Healthcare Conference<br \/><\/strong>Forum: Fireside Chat<br \/>Date: Wednesday, September 13, 2023<br \/>Time: 12:50 p.m. ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:left\">\n          <strong>2023 Cantor Fitzgerald Global Healthcare Conference<br \/><\/strong>Forum: Fireside Chat<br \/>Date: Tuesday, September 26, 2023<br \/>Time: 1:15 p.m. ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:left\">\n          <strong>JonesTrading 2023 Healthcare Summit<br \/><\/strong>Forum: Panel Discussion<br \/>Date: Tuesday, October 10, 2023<br \/>Time: 1:45 p.m. ET<\/li>\n<\/ul>\n<p align=\"justify\">A webcast and subsequent archived replay of the presentations and panel discussion may be accessed via the Investors section of the Company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZvGrKvBFlq1Mc-4v6CI3MkkBQS9tEgEcZAXanuAyCNk0ZG0g6kP85_AfIrM_OThacbVCAqg1Zu5h1Xoyy4zLR1si8PrD-Rqr-acxAKgexaM=\" rel=\"nofollow noopener\" target=\"_blank\">www.eyepointpharma.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About EyePoint Pharmaceuticals<\/strong>\n      <\/p>\n<p align=\"justify\">EyePoint Pharmaceuticals (Nasdaq: EYPT) is a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company&#8217;s pipeline leverages its proprietary erodible Durasert E\u2122 technology for sustained intraocular drug delivery including EYP-1901, an investigational sustained delivery intravitreal anti-VEGF treatment currently in Phase 2 clinical trials. The proven Durasert\u00ae drug delivery platform has been safely administered to thousands of patients&#8217; eyes across four U.S. FDA approved products. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts. For more information visit www.eyepointpharma.com.<\/p>\n<p align=\"justify\">\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Christina Tartaglia<br \/>Stern IR<br \/>Direct: 212-698-8700<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QONmQRzLprb61qK-CrgPv4lKsWayhOqeFNCPqpxD8dxockgH7VBjmbYz6Mh_0CSGyQMx5J_pLLltA6ZSSo-EhL-N20sJy7C1es6s-Jv7tdZMgr8dp8kqmpUxznk6SqPI\" rel=\"nofollow noopener\" target=\"_blank\">christina.tartaglia@sternir.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Amy Phillips<br \/>Green Room Communications<br \/>Direct: 412-327-9499<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PS4L-6Sqzq1H1TzWY14uwQAZWmHndpV6m0vPsTp7gvNi4Ms_kZweG8XmY7-QXWjUkfPf9obi40NvdmsVxVKRWW85aVVsXuFBNpeju6K55pN_g4PStM63glSUfGf_vbMn\" rel=\"nofollow noopener\" target=\"_blank\">aphillips@greenroompr.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/N2FmN2RiNDktOTU2ZS00OGQyLWEwMGEtYWVhNjNjMGI5ODcwLTEwMTczOTA=\/tiny\/EyePoint-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that the Company will participate at the following upcoming conferences: Citi&#8217;s 18 th Annual BioPharma ConferenceForum: 1&#215;1 Investor MeetingsDate: Wednesday, September 6, 2023 H.C. Wainwright 25 th Annual Global Investment ConferenceForum: Corporate PresentationDate: Monday, September 11, 2023Time: Available on-demand at 7:00 a.m. ET Baird 2023 Global Healthcare ConferenceForum: Fireside ChatDate: Wednesday, September 13, 2023Time: 12:50 p.m. ET 2023 Cantor Fitzgerald Global Healthcare ConferenceForum: Fireside ChatDate: Tuesday, September 26, 2023Time: 1:15 p.m. ET JonesTrading 2023 Healthcare SummitForum: Panel DiscussionDate: Tuesday, October 10, 2023Time: 1:45 p.m. ET A &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-780873","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that the Company will participate at the following upcoming conferences: Citi&#8217;s 18 th Annual BioPharma ConferenceForum: 1&#215;1 Investor MeetingsDate: Wednesday, September 6, 2023 H.C. Wainwright 25 th Annual Global Investment ConferenceForum: Corporate PresentationDate: Monday, September 11, 2023Time: Available on-demand at 7:00 a.m. ET Baird 2023 Global Healthcare ConferenceForum: Fireside ChatDate: Wednesday, September 13, 2023Time: 12:50 p.m. ET 2023 Cantor Fitzgerald Global Healthcare ConferenceForum: Fireside ChatDate: Tuesday, September 26, 2023Time: 1:15 p.m. ET JonesTrading 2023 Healthcare SummitForum: Panel DiscussionDate: Tuesday, October 10, 2023Time: 1:45 p.m. ET A &hellip; Continue reading &quot;EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T11:19:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences\",\"datePublished\":\"2023-08-30T11:19:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/\"},\"wordCount\":260,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/\",\"name\":\"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=\",\"datePublished\":\"2023-08-30T11:19:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/","og_locale":"en_US","og_type":"article","og_title":"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - Market Newsdesk","og_description":"WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that the Company will participate at the following upcoming conferences: Citi&#8217;s 18 th Annual BioPharma ConferenceForum: 1&#215;1 Investor MeetingsDate: Wednesday, September 6, 2023 H.C. Wainwright 25 th Annual Global Investment ConferenceForum: Corporate PresentationDate: Monday, September 11, 2023Time: Available on-demand at 7:00 a.m. ET Baird 2023 Global Healthcare ConferenceForum: Fireside ChatDate: Wednesday, September 13, 2023Time: 12:50 p.m. ET 2023 Cantor Fitzgerald Global Healthcare ConferenceForum: Fireside ChatDate: Tuesday, September 26, 2023Time: 1:15 p.m. ET JonesTrading 2023 Healthcare SummitForum: Panel DiscussionDate: Tuesday, October 10, 2023Time: 1:45 p.m. ET A &hellip; Continue reading \"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-30T11:19:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences","datePublished":"2023-08-30T11:19:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/"},"wordCount":260,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/","name":"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=","datePublished":"2023-08-30T11:19:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMjIxNSM1Nzg2Nzk2IzIwMDU4MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-8\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=780873"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780873\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=780873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=780873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=780873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}